Davita Inc vs FirstEnergy Corp. — how do they compare? Davita Inc trades at $179.47 (market cap $11.29B), while FirstEnergy Corp. trades at $45.01 (market cap $25.95B). The key difference: FirstEnergy Corp. is far larger — about 2.3× Davita Inc's market cap, and FirstEnergy Corp. pays a 4.15% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and FirstEnergy Corp. for 71 Days on average.
| DVA | FE | |
|---|---|---|
Market Cap | $11.29B | $25.95B |
Volume | 582,204 | 5,643,833 |
Sector | Health | Utilities |
52-Week High | $240.96 | $51.91 |
52-Week Low | $103.87 | $43.04 |
Typical Hold Time | 114 Days | 71 Days |
Enterprise Value | $24.01B | $54.87B |
Dividend Yield | — | 4.15% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $179.02, up 1.26% with consistent earnings beats in recent quarters. The stock shows bearish technical signals but maintains strong fundamentals with 6.05% net margins and 635% ROE. Recent partnerships with Humana expand value-based kidney care services, while institutional investors like BlackRock added significant positions. Revenue growth remains steady at $13.6B annually with improving profitability trends.
DVA presents a mixed outlook with strong operational performance offset by technical weakness. The 43% upside to consensus price target of $235.67 offers potential, but high debt levels and regulatory risks require monitoring. Recent earnings momentum and expanding Medicare partnerships support long-term growth, though current technical indicators suggest near-term consolidation.
FirstEnergy (FE) trades at $44.93, up 0.79% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.50, slightly missing expectations, while Q1 beat estimates. Revenue grew to $15.09B in 2025 with a 6.86% net margin. Analysts maintain a Moderate Buy rating with a $52.80 price target, representing 17.5% upside. Recent news highlights the $36B Energize365 investment plan and consistent dividend payments.
FirstEnergy presents a stable utility investment with steady revenue growth and dividend yield, though elevated debt levels and inconsistent earnings performance pose risks. The stock's current valuation at 23.98 P/E appears reasonable given the utility sector's defensive characteristics. Upside potential exists if the company can consistently meet earnings expectations and execute its capital investment program effectively.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →